This pairing represents a true biohacking approach to skin rejuvenation, merging science-backed regenerative ingredients with a technique that stimulates the skins natural healing response
Nausea and Vomiting Nausea is the most commonly reported side effect of semaglutide, with around 44% of people using Wegovy, experiencing nausea during clinical trials resulting in 6.8% of patients permanently discontinuing treatment as the result of adverse reactions
Over 816 weeks, however, metabolic adaptation begins: your brain becomes less sensitive to the medication's appetite-suppressing effects, and your body's baseline hunger hormones shift back toward their original set point
As a result, it not only helps control blood sugar in Type 2 diabetes patients but also promotes weight loss, making it a potential treatment for obesity
The SURMOUNT-5 trial, published in The New England Journal of Medicine , directly compared tirzepatide to semaglutide and found tirzepatide produced 47% greater relative weight loss at 72 weeks, 20.2% of body weight versus 13.7%
